initial trimester blended screening for aneuploidy continues to be the main focus of intensive investigate. designs incorporate maternal traits and serum biochemical markers with nuchal translucency so as to predict adverse results. The amounts of some biochemical markers are altered in SGA and FGR pregnancies. A lifted maternal serum alpha-fetopro